TRB Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$347K Buy
5,554
+1,012
+22% +$64K 0.05% 193
2026
Q2
$262K Buy
4,542
+89
+2% +$5.11K 0.03% 232
2026
Q1
$270K Buy
+4,453
New +$260K 0.04% 218

Other funds holding BMY

TRB Wealth Management's BMY Position: Q3 2026 in Review

TRB Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 22% in Q3 2026, buying an estimated $64K and bringing the position to 5,554 shares worth $347K. The position accounts for 0.05% of the portfolio, ranked #193.

TRB Wealth Management first reported a position in BMY in Q1 2026 and has held it in 3 quarters since. 2,570 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • TRB Wealth Management held 5,554 shares of Bristol-Myers Squibb worth $347K as of Q3 2026.
  • TRB Wealth Management bought 1,012 Bristol-Myers Squibb shares in Q3 2026, an estimated $64K.
  • Bristol-Myers Squibb made up 0.05% of TRB Wealth Management's portfolio in Q3 2026, its #193 holding.
  • TRB Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 3 quarters since.
  • 2,570 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on TRB Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.